Form4insider filings, from the source

SEC Form 4 · accession 0001652252-18-000087

BIO-RAD LABORATORIES, INC. · BIO BIO.B

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Sep 11, 2018
Accepted (ET)
Sep 13, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Bio-Rad B Common StockF1Sep 11, 2018M5,800$0.00A264,465D
Bio-Rad B Common StockSep 11, 2018F2,877$308.37D261,588D
Bio-Rad A Common Stockholding———412,562D
Bio-Rad B Common StockF2holding———12,717IBy Spouse
Bio-Rad B Common StockF3holding———4,060,054IBy Blue Raven Partners, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5$0.00Sep 11, 2018M2,600D——Bio-Rad B Common Stock2,6000D
Restricted Stock UnitsF4,F6$0.00Sep 11, 2018M3,200D——Bio-Rad B Common Stock3,2006,400D

Explanation of responses